Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$38.04 – $54.50
1% from low
Exchange
OTC Link
ADRC
Borrow rate
9.46%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.34B | $18.64B | $19.29B | $20.89B | $25.39B | $30.61B | $33.46B | $35.99B |
| Cost of revenue | $13.58B | $14.56B | $15.07B | $16.39B | $20.05B | $24.36B | $26.61B | $28.53B |
| Gross profit | $3.76B | $4.08B | $4.23B | $4.50B | $5.33B | $6.25B | $6.85B | $7.43B |
| Gross margin | 21.7% | 21.9% | 21.9% | 21.5% | 21.0% | 20.4% | 20.5% | 20.7% |
| R&D | $2.5M | $2.9M | $3.0M | $0 | $0 | $0 | $0 | $0 |
| Operating income | $586.7M | $706.0M | $638.9M | $806.0M | $976.0M | $1.24B | $1.07B | $1.26B |
| EBITDA | $947.1M | $1.42B | $1.34B | $1.54B | $1.76B | $2.15B | $2.16B | $2.38B |
| Net income | $401.0M | $389.9M | $312.0M | $463.0M | $590.0M | $756.0M | $599.0M | $621.5M |
| Net margin | 2.3% | 2.1% | 1.6% | 2.2% | 2.3% | 2.5% | 1.8% | 1.7% |
| EPS (diluted) | 1.28 | 1.24 | 1.00 | 1.48 | 1.88 | 2.40 | 1.90 | 3.94 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $39.4B | $2.49 | $2.35–$2.62 | 1 |
| 2027 | $41.9B | $2.82 | $2.74–$2.89 | 2 |
| 2028 | $44.4B | $3.19 | $3.14–$3.21 | 1 |
| 2029 | $47.0B | $3.63 | $3.57–$3.65 | 1 |
Forward consensus · source: Financial Modeling Prep
JERONIMO MARTINS UNSP/ADR
No one on the platform currently holds JRONY.
No tracked institution reports a position in JRONY as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-11 | $1.5255 | |
| 2025-05-19 | $1.3196 | 2025-05-30 |
| 2024-05-13 | $1.4165 | 2024-05-30 |
No one on the platform has traded JRONY yet.
| +2.95% |
| $7.5B |
| — |
| EMLAFEmpire Company Limited | $35.12 | -2.58% | $7.9B | — |
| KIKOYKikkoman Corporation | $21.55 | +0.00% | $10.0B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 19.3× earnings vs its 21.5× historical median P/E.
Fair value ≈ $42.53 · price $38.23 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.